Home › Lupus › Texas › El Paso
Lupus clinical trials in El Paso, TX
4 studies for Lupus are looking for participants at sites in and around El Paso (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
RecruitingObservational study
- El Paso Medical Research Institute (MedResearch, Inc), El Paso
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50781, El Paso
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
RecruitingPhase 3
- Research Site, El Paso
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
RecruitingPhase 3
- Texas Arthritis Center, El Paso
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX14 studies
- Durham, NC12 studies
- Washington, DC11 studies
- Miami, FL10 studies
- Oklahoma City, OK9 studies
- San Diego, CA8 studies
- Tampa, FL8 studies
- Boston, MA8 studies
- Chicago, IL8 studies
- Philadelphia, PA8 studies
- Santa Monica, CA7 studies
Other studies in El Paso
- Obesity8 studies
- Breast Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Overweight6 studies
- Heart Failure6 studies
- Metastatic Cancer5 studies
- COPD5 studies
- Idiopathic Pulmonary Fibrosis5 studies
- Burkitt Lymphoma4 studies
- Alzheimer's Disease4 studies
- Migraine4 studies
- Graves Disease4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.